0001924038-22-000001.txt : 20220420 0001924038-22-000001.hdr.sgml : 20220420 20220420095429 ACCESSION NUMBER: 0001924038-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220420 DATE AS OF CHANGE: 20220420 EFFECTIVENESS DATE: 20220420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amalgent Therapeutics, LLC CENTRAL INDEX KEY: 0001924038 IRS NUMBER: 844925461 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-442672 FILM NUMBER: 22836581 BUSINESS ADDRESS: STREET 1: 206 PEBBLE SPRINGS ROAD CITY: CHAPEL HILL STATE: NC ZIP: 27514 BUSINESS PHONE: 919-923-1846 MAIL ADDRESS: STREET 1: 206 PEBBLE SPRINGS ROAD CITY: CHAPEL HILL STATE: NC ZIP: 27514 D 1 primary_doc.xml X0708 D LIVE 0001924038 Amalgent Therapeutics, LLC 206 PEBBLE SPRINGS ROAD CHAPEL HILL NC NORTH CAROLINA 27514 919-923-1846 DELAWARE None None Limited Liability Company true 2020 Malcolm A Meyn c/o Amalgent Therapeutics, LLC 206 Pebble Springs Road Chapel Hill NC NORTH CAROLINA 27514 Executive Officer Director Sam Tetlow c/o Amalgent Therapeutics, LLC 206 Pebble Springs Road Chapel Hill NC NORTH CAROLINA 27514 Director Pharmaceuticals Decline to Disclose 06b false 2022-04-04 false true false 0 1000000 200000 800000 false 1 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director, manager or promoter will receive any payments from the proceeds of this offering. false Amalgent Therapeutics, LLC /s/ Malcolm A. Meyn Malcolm A. Meyn Chief Scientific Officer 2022-04-20